8-K: BIO-key Reports Q1 2025 Revenue of $1.6M, Cash Position Improves to $3.1M

BIO-key International reports a 25% year-over-year revenue decrease for Q1 2025, but highlights a strengthened cash position and strategic partnerships.

Summary

• BIO-key International, Inc. announced its Q1 2025 financial results, reporting revenue of $1.6 million.
• This represents a 25% decrease compared to Q1 2024, primarily due to a large contract renewal in the previous year.
• However, revenue increased approximately 10% sequentially compared to Q4 2024.
• The company's gross margin remained healthy at 83%.
• BIO-key reduced its selling, general, and administrative expenses by 23% year-over-year.
• The company's cash position improved substantially to $3.1 million due to warrant exercises.
• BIO-key experienced a net loss of $736,545, or ($0.16) per share, compared to a net loss of $510,285, or ($0.32) per share, in Q1 2024.
• The company is transitioning to selling higher-margin BIO-key branded products in EMEA.
• BIO-key expects revenue from a long-term financial services customer to increase significantly in 2026.
• The company is focused on identity bound biometric solutions in defense/security and financial services.
• BIO-key serves over 100 institutions with over 4 million end users in the SLED market.
• The company is uniquely positioned to comply with California's Phone-Free Schools Act (AB-1326).
• BIO-key feels well positioned to deliver improved topand bottom-line results in 2025.

Sentiment

Score: 6

Explanation: While the company reports a year-over-year revenue decrease and a net loss, there are positive aspects such as sequential revenue growth, a strong gross margin, reduced operating expenses, and a strengthened cash position. The company also highlights strategic partnerships and a positive outlook for the future.

Positives

• Sequential revenue increased by approximately 10% compared to Q4 2024.
• Gross margin remained healthy at 83%.
• Selling, general, and administrative expenses were reduced by 23% year-over-year.
• Cash position improved substantially to $3.1 million.
• Strategic partnerships were formed to expand market reach.
• The company is well-positioned to comply with California's Phone-Free Schools Act.

Negatives

• Year-over-year revenue decreased by 25% due to the timing of a large contract renewal.
• Net loss increased to $736,545, or ($0.16) per share, compared to $510,285, or ($0.32) per share, in Q1 2024.
• License fee revenue decreased due to the variance in revenue from the long-term financial services customer, as well as the impact on revenue of transitioning from selling third-party Swivel Secure products and services to BIO-key products, in the EMEA region.

Risks

• The timing of large customer orders or renewals may cause financial performance to fluctuate on a quarter-to-quarter basis.
• The company faces risks related to its history of losses and limited revenue.
• BIO-key's ability to raise additional capital to satisfy working capital needs is a risk.
• The company's ability to continue as a going concern is a risk.
• BIO-key faces competition in the biometric technology and identity access management industries.
• Market acceptance of biometric products generally and BIO-key's products under development is a risk.
• The company's ability to convert sales opportunities to customer contracts is a risk.
• BIO-key's ability to expand into Asia, Africa and other foreign markets is a risk.
• The company's ability to migrate Swivel Secure customers to BIO-key and Portal Guard offerings is a risk.
• Fluctuations in foreign currency exchange rates pose a risk.
• The duration and extent of continued hostilities in Ukraine and its impact on BIO-key's European customers is a risk.
• The impact of tariffs and other trade barriers which may make it more costly for BIO-key to import inventory from China and Hong Kong and certain product components from South Korea is a risk.
• Delays in the development of products pose a risk.
• The commercial, reputational and regulatory risks to BIO-key's business that may arise as a consequence of the restatement of its financial statements, including any consequences of non-compliance with Securities and Exchange Commission and Nasdaq periodic reporting requirements is a risk.
• BIO-key's temporary loss of the use of a Registration Statement on Form S-3 to register securities in the future is a risk.
• Any disruption to BIO-key's business that may occur on a longer-term basis should it be unable to continue to maintain effective internal controls over financial reporting is a risk.

Future Outlook

BIO-key anticipates improved topand bottom-line results in 2025, driven by increasing interest in biometric solutions, adoption of passwordless IAM, a stronger balance sheet, and revenue traction in EMEA markets. The company also seeks to reduce costs to support positive cash flow and profitability.

Management Comments

• Our revenue rose approximately 10% sequentially vs. Q424, as we continue our transition to selling high-margin BIO-key branded products in Europe, the Middle East and Africa (EMEA).
• We expect revenue from this customer to increase significantly in the next two-year period commencing in 2026, due to their expanding deployment and the addition of our one-to-many fingerprint-only biometric ID system that requires no card or account number for client Identification.
• Moving forward, we are seeing growing traction for our identity bound biometric solutions in defense/security and financial services applications that require the highest levels of security.
• We see growing interest in our unique passwordless, phoneless and tokenless authentication solutions, which meet the most pressing security and usability challenges.
• Based on the security, flexibility, ease of deployment and compelling ROI provided by our solutions, we feel well positioned to deliver improved topand bottom-line results in 2025.

Industry Context

BIO-key's focus on passwordless, phoneless, and tokenless authentication aligns with the growing industry trend towards more secure and user-friendly identity and access management solutions. The company's expansion in the SLED market and its compliance with California's Phone-Free Schools Act position it well within the evolving regulatory landscape.

Comparison to Industry Standards

• Comparing BIO-key's gross margin of 83% to industry peers like Ping Identity (around 75%) and Okta (around 72%) suggests a strong margin profile.
• However, BIO-key's revenue scale is significantly smaller than these larger competitors.
• BIO-key's focus on biometric authentication provides a niche offering compared to broader IAM solutions from companies like Microsoft and IBM.
• The company's success in securing government and defense contracts aligns with trends seen in companies like Thales and Safran Identity & Security.

Stakeholder Impact

• Shareholders may be concerned about the year-over-year revenue decrease and net loss, but encouraged by the improved cash position and strategic partnerships.
• Employees may be affected by cost reduction efforts.
• Customers may benefit from the company's focus on innovative and secure IAM solutions.
• Suppliers may be impacted by changes in the company's procurement strategies.
• Creditors may be reassured by the improved cash position.

Next Steps

• The company intends to monitor the closing bid price of its common stock and may consider available options to regain compliance with the Bid Price Rule.
• BIO-key will continue to seek opportunities to reduce costs and lower its breakeven level to support its path to positive cash flow and profitability.

Key Dates

Keywords

BIO-key, biometrics, IAM, identity access management, authentication, passwordless, PortalGuard, revenue, financial results, Q1 2025